OBJECTIVES: Authors compared the degrees of cognitive deficit among individuals with Alzheimer disease (AD), the Lewy-body variant of AD (LBV), and "pure" dementia with Lewy bodies (DLB); and compared cortical Lewy body (LB) counts in LBV versus DLB and neuritic plaque and neurofibrillary tangle severity in LBV versus AD. METHODS: Authors examined brain specimens from consecutive autopsies of elderly nursing home subjects. Numbers and densities of plaques, Lewy bodies, and tangle severity were determined in multiple cortical regions, and demographic and clinical variables were compared among the three groups. RESULTS: The three groups did not differ in demographic or clinical variables. The LBV group was significantly more impaired than the other groups. Cortical LB counts were significantly higher in LBV than in DLB. There was no evidence of increased plaque or tangle severity in LBV than in AD. CONCLUSION: The co-occurrence of AD and LB pathology is associated with higher numbers of LBs and more severe dementia than when classical AD or LB lesions occur alone.
OBJECTIVES: Authors compared the degrees of cognitive deficit among individuals with Alzheimer disease (AD), the Lewy-body variant of AD (LBV), and "pure" dementia with Lewy bodies (DLB); and compared cortical Lewy body (LB) counts in LBV versus DLB and neuritic plaque and neurofibrillary tangle severity in LBV versus AD. METHODS: Authors examined brain specimens from consecutive autopsies of elderly nursing home subjects. Numbers and densities of plaques, Lewy bodies, and tangle severity were determined in multiple cortical regions, and demographic and clinical variables were compared among the three groups. RESULTS: The three groups did not differ in demographic or clinical variables. The LBV group was significantly more impaired than the other groups. Cortical LB counts were significantly higher in LBV than in DLB. There was no evidence of increased plaque or tangle severity in LBV than in AD. CONCLUSION: The co-occurrence of AD and LB pathology is associated with higher numbers of LBs and more severe dementia than when classical AD or LB lesions occur alone.
Authors: M S Beeri; M Rapp; J M Silverman; J Schmeidler; H T Grossman; J T Fallon; D P Purohit; D P Perl; A Siddiqui; G Lesser; C Rosendorff; V Haroutunian Journal: Neurology Date: 2006-05-09 Impact factor: 9.910
Authors: Michal Schnaider Beeri; Vahram Haroutunian; James Schmeidler; Mary Sano; Peter Fam; Aaron Kavanaugh; Alasdair M Barr; William G Honer; Pavel Katsel Journal: Neurobiol Aging Date: 2011-12-27 Impact factor: 4.673
Authors: Eun Joo Chung; Ganesh M Babulal; Sarah E Monsell; Nigel J Cairns; Catherine M Roe; John C Morris Journal: JAMA Neurol Date: 2015-07 Impact factor: 18.302
Authors: Michal Schnaider Beeri; Michael Rapp; James Schmeidler; Abraham Reichenberg; Dushyant P Purohit; Daniel P Perl; Hillel T Grossman; Isak Prohovnik; Vahram Haroutunian; Jeremy M Silverman Journal: Neurobiol Aging Date: 2008-01-10 Impact factor: 4.673
Authors: Leslie S Libow; Pasquale G Frisina; Vahram Haroutunian; Daniel P Perl; Dushyant P Purohit Journal: Parkinsonism Relat Disord Date: 2009-04-05 Impact factor: 4.891
Authors: Angela Nervi; Christiane Reitz; Ming-Xin Tang; Vincent Santana; Angel Piriz; Dolly Reyes-Dumeyer; Rafael Lantigua; Martin Medrano; Ivonne Z Jiménez-Velázquez; Joseph H Lee; Richard Mayeux Journal: Arch Neurol Date: 2008-12
Authors: Lauren Walker; Kirsty E McAleese; Mary Johnson; Ahmad A Khundakar; Daniel Erskine; Alan J Thomas; Ian G McKeith; Johannes Attems Journal: J Neural Transm (Vienna) Date: 2017-03-06 Impact factor: 3.575
Authors: Tiago Fleming Outeiro; David J Koss; Daniel Erskine; Lauren Walker; Marzena Kurzawa-Akanbi; David Burn; Paul Donaghy; Christopher Morris; John-Paul Taylor; Alan Thomas; Johannes Attems; Ian McKeith Journal: Mol Neurodegener Date: 2019-01-21 Impact factor: 14.195